Exact Mass: 400.08173780000004

Exact Mass Matches: 400.08173780000004

Found 62 metabolites which its exact mass value is equals to given mass value 400.08173780000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-Demethylpremithramycinone

C20H16O9 (400.0794)

Versiconal hemiacetal acetate

(2S,3S)-versiconal hemiacetal acetate

C20H16O9 (400.0794)

An anthrafuran that is 2,3-dihydroanthra[2,3-b]furan-5,10-dione substituted at positions 2, 4, 6 and 8 by hydroxy groups and at position 3 by a 2-acetoxyethyl group. An intermediate in the biosynthesis of aflatoxin.

Theaflagallin

2,3,4,5-tetrahydroxy-8-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)-6H-benzo[7]annulen-6-one

C20H16O9 (400.0794)

Red pigment from black tea (Camellia sinensis variety assamica). Theaflagallin is found in tea. Epitheaflagallin is found in tea. Epitheaflagallin is a pigment from black tea.

TRICIRIBINE PHOSPHATE

[(5-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.0^{4,12}]dodeca-1(12),3,5,8,10-pentaen-2-yl}-3,4-dihydroxyoxolan-2-yl)methoxy]phosphonic acid

C13H17N6O7P (400.0896)

Paeciloquinone B

(+-)-9,10-Dihydro-1,3,6,8-tetrahydroxy-9,10-dioxo-a-(3-oxobutyl)-2-anthraceneacetic acid

C20H16O9 (400.0794)

3,5,7,4-Tetrahydroxy-8-C-(3-methylsuccinoyl)flavone

3,5,7-Trihydroxy-2- (4-hydroxyphenyl) -alpha-methyl-gamma,4-dioxo-4H-1-benzopyran-8-butanoic acid

C20H16O9 (400.0794)

3,5,8-Trimethoxy-6,7:3,4-bis(methylenedioxy)flavone

6- (1,3-Benzodioxol-5-yl) -4,7,9-trimethoxy-8H-1,3-dioxolo [ 4,5-g ] [ 1 ] benzopyran-8-one

C20H16O9 (400.0794)

1,2,8-triacetoxy-6-methoxy-xanthen-9-one|1,7,8-Triacetoxy-3-methoxyxanthon|gentiakochianin acetate

C20H16O9 (400.0794)

cercophorin A

C20H16O9 (400.0794)

4-dehydro-deacetylgriseusin A

C20H16O9 (400.0794)

Glutinoside

C14H21ClO11 (400.0772)

DTXSID30966362

C20H16O9 (400.0794)

methyl 3-O-methylvariegatate

C20H16O9 (400.0794)

4-O-Demethyladriamycinone

C20H16O9 (400.0794)

Theaflagallin

2,3,4,6-tetrahydroxy-8-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)-5H-benzo[7]annulen-5-one

C20H16O9 (400.0794)

2-Phenyl-2-imidazoline pyromellitate

C19H16N2O8 (400.0907)

N-(4-((4-CHLORO-6-((5-METHYL-1H-PYRAZOL-3-YL)AMINO)PYRIMIDIN-2-YL)THIO)PHENYL)CYCLOPROPANECARBOXAMIDE

C18H17ClN6OS (400.0873)

Urea, N-[2-(trifluoromethyl)-1,8-naphthyridin-3-yl]-N-[3-(trifluoromethyl)phenyl]- (9CI)

C17H10F6N4O (400.0759)

5-IODO-1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE

C16H25IN2Si (400.0832)

3-IODO-1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE

C16H25IN2Si (400.0832)

2,3,7,8-Tetraacetoxydibenzofuran

C20H16O9 (400.0794)

5,6-DIAMINO-2,4-DIHYDROXYPYRIMIDINE SULFATE DIHYDRATE

C8H16N8O9S (400.0761)

TRICIRIBINE PHOSPHATE

1,4,5,6,8-Pentaazaacenaphthylen-3-amine

C13H17N6O7P (400.0896)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C471 - Enzyme Inhibitor > C2254 - Amidophosphoribosyltransferase Inhibitor

4-chlorophenylguanidine carbonate

C15H18Cl2N6O3 (400.0817)

2,2-BIPYRIDINIUM-N,N-DI(PROPYLSULFONATE)

C16H20N2O6S2 (400.0763)

JQ-1 carboxylic acid

C19H17ClN4O2S (400.0761)

N-(2,2-DIMETHOXYETHYL)-6-(5-(PHENYLTHIO)THIOPHEN-2-YL)NICOTINAMIDE

C20H20N2O3S2 (400.0915)

Benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C23H16N2O3S (400.0882)

9,10-Anthracenedione, 2-(3-(acetyloxy)-1-(hydroxymethyl)propyl)-1,3,6,8-tetrahydroxy-, (-)-

C20H16O9-2 (400.0794)

Demethylpremithracinone

C20H16O9 (400.0794)

[1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyindol-3-yl]methylcarbamodithioic acid

C16H20N2O6S2 (400.0763)

2,3,4,6-tetrahydroxy-8-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulen-5-one

C20H16O9 (400.0794)

4-[(Z)-(4-oxo-3-phenyl-2-phenylimino-1,3-thiazolidin-5-ylidene)methyl]benzoic acid

C23H16N2O3S (400.0882)

N-[4-chloro-2-[(2,4-dimethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide

C20H17ClN2O5 (400.0826)

cimicifugate K

C20H16O9-2 (400.0794)

1-[5-Hydroxy-8-(2-hydroxypropan-2-yl)-2-oxo-8,9-dihydrouro[2,3-h]chromen-4-yl]propyl hydrogen sulate

C17H20O9S (400.0828)

1-[5-Hydroxy-8-(2-hydroxypropan-2-yl)-2-oxo-8,9-dihydrouro[2,3-h]chromen-4-yl]propan-2-yl hydrogen sulate

C17H20O9S (400.0828)

3-Acetyl-4,4a,6,7,9,12a-hexahydroxy-1,12-dihydrotetracene-2,5-dione

C20H16O9 (400.0794)

(2S,3S)-versiconal hemiacetal acetate

C20H16O9 (400.0794)

An optically active form of versiconal hemiacetal acetate having 2S,3S-configuration.

Demethylpremithramycinone

C20H16O9 (400.0794)

LPG 7:3;O3

C13H21O12P (400.0771)

MRK-898

C20H9F5N4 (400.0747)

MRK-898 is an orally active GABA(A) receptor modulator. MRK-898 binds to α1, α2, α3 or α5 subunit of GABA(A) receptor with Ki values of 1.2 nM, 1.0 nM, 0.73 nM, and 0.50 nM, respectively. However, α1-containing GABA(A) receptors are identified as the "sedative" and α2- and/or α3-containing receptors as the "anxiolytic" subtype(s)[1].